Current guidelines for advanced breast cancer do not recommend routine brain imaging in neurologically asymptomatic patients. Prospective clinical evidence on the effectiveness of screening for early detection of brain metastasis (BM) remains limited. We conducted a prospective cohort study to evaluate the utility of magnetic resonance imaging (MRI) screening in patients with advanced human epidermal growth factor receptor 2-positive (HER2+) or triple-negative breast cancer (TNBC).
ESMO Open published a clinical update in Oncology on 11 Mar 2026.
The item focuses on A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer☆.
Review the original article for the full source wording and details.